Blueprint Medicines, a Sanofi company, today announced AYVAKIT(R) (avapritinib) data showing clinically meaningful outcomes and a w ...
Real-world study of AYVAKIT highlights improvement across ISM symptoms ---- 12 data presentations at 2026 AAAAI Annual ...
There has been concern about measles cases in various parts of the United States and a significant uptick worldwide. Accordin ...
Chief Executive Officer and co-founder Ben Zeskind told attendees at Oppenheimer’s 36th Annual Healthcare Life Sciences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results